Jie Peng Selected Research

Jie Peng Research Topics

Disease

46	Neoplasms (Cancer) 01/2022 - 12/2006
36	Chronic Hepatitis B 12/2022 - 09/2003
26	Infections 06/2022 - 05/2008
17	Inflammation (Inflammations) 08/2022 - 09/2003
12	Fibrosis (Cirrhosis) 06/2020 - 09/2003
9	Neoplasm Metastasis (Metastasis) 09/2021 - 03/2010
8	Insulin Resistance 08/2022 - 07/2011
8	Hepatitis B 06/2021 - 09/2003
7	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2014
6	Pancreatitis 06/2022 - 03/2018
6	Retinal Detachment (Retinal Detachments) 01/2022 - 01/2017
6	Obesity 11/2021 - 09/2017
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 05/2015
5	Carcinogenesis 01/2022 - 03/2010
5	Breast Neoplasms (Breast Cancer) 07/2020 - 03/2010
5	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020 - 08/2013
5	Liver Cirrhosis (Hepatic Cirrhosis) 05/2018 - 10/2004
5	Stomach Neoplasms (Stomach Cancer) 09/2017 - 12/2006
4	Retinopathy of Prematurity (Retrolental Fibroplasia) 09/2022 - 01/2017
4	Renal Insufficiency (Renal Failure) 04/2022 - 01/2018
4	Retinal Perforations 01/2022 - 11/2018
4	Glaucoma 01/2022 - 01/2006
4	Disease Progression 01/2021 - 01/2017
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2018 - 02/2015
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016 - 01/2013
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 09/2019
3	Sepsis (Septicemia) 09/2021 - 01/2021
3	Lung Neoplasms (Lung Cancer) 09/2021 - 01/2013
3	Abdominal Obesity 01/2021 - 02/2015
3	Body Weight (Weight, Body) 01/2021 - 10/2018
3	Ischemia 11/2020 - 09/2011
3	Esophageal Squamous Cell Carcinoma 05/2020 - 06/2019
3	Wounds and Injuries (Trauma) 01/2020 - 01/2015
3	Hypertension (High Blood Pressure) 10/2018 - 01/2014
3	Necrosis 03/2018 - 12/2011
3	Atherosclerosis 12/2011 - 01/2011
3	Carcinoma (Carcinomatosis) 12/2011 - 01/2009
2	Mitochondrial Diseases (Mitochondrial Disease) 08/2022 - 09/2021
2	Acquired Immunodeficiency Syndrome (AIDS) 06/2022 - 10/2021
2	Thrombosis (Thrombus) 04/2022 - 01/2021
2	Incontinentia Pigmenti (Bloch Sulzberger Syndrome) 03/2022 - 01/2018
2	Cataract (Cataracts) 02/2022 - 01/2016
2	Virus Diseases (Viral Diseases) 01/2022 - 01/2019
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 11/2017

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2006
12	Pharmaceutical PreparationsIBA 04/2022 - 12/2008
12	Hepatitis B e AntigensIBA 01/2021 - 09/2003
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2013
11	DNA (Deoxyribonucleic Acid)IBA 06/2021 - 09/2003
10	RNA (Ribonucleic Acid)IBA 12/2022 - 03/2010
10	LipidsIBA 11/2021 - 01/2011
10	Antiviral Agents (Antivirals)IBA 06/2021 - 01/2009
9	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022 - 06/2008
7	Messenger RNA (mRNA)IBA 01/2022 - 01/2006
7	InterferonsIBA 06/2021 - 06/2005
7	Small Interfering RNA (siRNA)IBA 04/2018 - 12/2011
6	MicroRNAs (MicroRNA)IBA 06/2019 - 11/2016
5	Retinaldehyde (Retinal)IBA 09/2022 - 01/2016
5	Ranibizumab (Lucentis)FDA Link 09/2022 - 01/2017
5	AntigensIBA 01/2022 - 01/2020
5	VaccinesIBA 01/2022 - 01/2020
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 10/2018
5	Sirtuin 1IBA 09/2021 - 09/2017
5	Telbivudine FDA Link 01/2020 - 06/2012
5	entecavir FDA Link 06/2017 - 06/2011
4	AntioxidantsIBA 08/2022 - 01/2011
4	Carbapenems (Carbapenem Antibiotics)IBA 06/2022 - 10/2018
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 07/2011
4	adefovirIBA 01/2020 - 01/2009
4	AlbuminsIBA 11/2019 - 09/2011
4	Alanine Transaminase (SGPT)IBA 01/2019 - 01/2012
4	Celecoxib (Celebrex)FDA Link 09/2017 - 06/2004
4	BilirubinIBA 07/2012 - 10/2004
3	ProcalcitoninIBA 06/2022 - 01/2021
3	CytokinesIBA 03/2022 - 03/2018
3	Interleukin-10 (Interleukin 10)IBA 11/2021 - 06/2005
3	Long Noncoding RNAIBA 07/2021 - 04/2018
3	LigandsIBA 01/2021 - 01/2020
3	Telomerase (Telomerase Reverse Transcriptase)IBA 02/2020 - 06/2016
3	AntibodiesIBA 01/2019 - 01/2009
3	Insulin (Novolin)FDA Link 12/2018 - 07/2011
3	CholesterolIBA 12/2018 - 01/2016
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2016
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2016 - 12/2011
3	calcium phosphateIBA 06/2016 - 12/2006
3	glutathione S-transferase T1IBA 09/2015 - 01/2013
2	nasIBA 12/2022 - 01/2021
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
2	Capsules (Microcapsules)IBA 01/2022 - 11/2018
2	Uric Acid (Urate)IBA 01/2022 - 02/2017
2	Triglycerides (Triacylglycerol)IBA 01/2022 - 12/2018
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2021 - 01/2016

Therapy/Procedure

43	Therapeutics 12/2022 - 10/2004
6	Hematopoietic Stem Cell Transplantation 12/2021 - 08/2013
5	Transplantation 01/2022 - 08/2013
4	Vitrectomy 01/2022 - 01/2017
4	Aftercare (After-Treatment) 01/2022 - 02/2017
3	Lasers (Laser) 01/2022 - 01/2017
3	Intravitreal Injections 01/2018 - 01/2012
2	Length of Stay 03/2022 - 01/2021